← Back to Search

Behavioral Intervention

App-Based Contingency Management for Substance Use Disorders

N/A

Recruiting

Led By Michael Fendrich, PhD

Research Sponsored by Aurora Health Care

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial will test whether app-based incentives are effective for older adults with substance use disorders, and if so, how to optimize the size of incentives over time.

Who is the study for?

Adults with opioid, cocaine, or methamphetamine use disorders who are in substance treatment programs can join. They must have a smartphone and be willing to use the DynamiCare app. Ideal candidates recently started treatment or used substances within the last 21 days. Those with active psychosis or significant cognitive impairment that affects participation cannot join.Check my eligibility

What is being tested?

The trial is testing if an app called DynamiCare, which offers incentives for staying drug-free, works well for older adults compared to younger ones. Participants will either get real incentives through the app or be in a control group without real rewards.See study design

What are the potential side effects?

Since this trial involves using an app rather than medication, there aren't typical medical side effects. However, participants may experience frustration or stress if they struggle with using technology or do not earn the expected incentives.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

App uptake

Drug-negative saliva tests

Secondary outcome measures

Longest period of continuous abstinence

Trial Design

7Treatment groups

Experimental Treatment

Placebo Group

Group I: Escalating LowExperimental Treatment1 Intervention

Participants will have access to the DynamiCare app. Through the app, participants will receive incentive amounts for drug negative saliva tests. Incentive amounts increase with every negative drug test up to a ceiling and "reset" to the lowest amount when a test is positive or missed. The "Low" group will receive lower incentive amounts than the "High" group.

Group II: Escalating HighExperimental Treatment1 Intervention

Participants will have access to the DynamiCare app. Through the app, participants will receive incentive amounts for drug negative saliva tests. Incentive amounts increase with every negative drug test up to a ceiling and "reset" to the lowest amount when a test is positive or missed. The "High" group will receive higher incentive amounts than the "Low" group.

Group III: De-Escalating LowExperimental Treatment1 Intervention

Participants will have access to the DynamiCare app. Through the app, participants will receive incentive amounts for drug negative saliva tests. Incentive amounts increase with every positive drug tests (up to a ceiling), and decrease by the same increment with every negative drug test (down to a floor). The "Low" group will receive lower incentive amounts than the "High" group.

Group IV: De-Escalating HighExperimental Treatment1 Intervention

Participants will have access to the DynamiCare app. Through the app, participants will receive incentive amounts for drug negative saliva tests. Incentive amounts increase with every positive drug tests (up to a ceiling), and decrease by the same increment with every negative drug test (down to a floor). The "High" group will receive higher incentive amounts than the "Low" group.

Group V: Constant LowExperimental Treatment1 Intervention

In the Constant groups, incentive amounts will remain unchanged across time. The "Low" group will receive lower incentive amounts than the "High" group.

Group VI: Constant HighExperimental Treatment1 Intervention

In the Constant groups, incentive amounts will remain unchanged across time. The "High" group will receive higher incentive amounts than the "Low" group.

Group VII: ControlPlacebo Group1 Intervention

Participants in this group will have access to the DynamiCare app; however, no behavioral incentives will be provided to this group.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ChicagoOTHER

1,003 Previous Clinical Trials

819,149 Total Patients Enrolled

Aurora Health CareLead Sponsor

42 Previous Clinical Trials

15,432 Total Patients Enrolled

University of California, Santa CruzOTHER

4 Previous Clinical Trials

1,521 Total Patients Enrolled

Media Library

DynamiCare app (app-based contingency management) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05521854 — N/A

Opioid Use Disorder Research Study Groups: Constant High, Control, De-Escalating Low, Escalating High, Constant Low, De-Escalating High, Escalating Low

Opioid Use Disorder Clinical Trial 2023: DynamiCare app (app-based contingency management) Highlights & Side Effects. Trial Name: NCT05521854 — N/A

DynamiCare app (app-based contingency management) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05521854 — N/A

Opioid Use Disorder Patient Testimony for trial: Trial Name: NCT05521854 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the usage of DynamiCare increase risks for participants?

"Our team at Power assessed DynamiCare app's (app-based contingency management) safety on a scale from 1 to 3, rating it as 2 due to the fact that there is some data indicating its security but none showing efficacy."

Answered by AI

Are there any unoccupied positions for individuals to receive this treatment?

"According to the records on clinicaltrials.gov, it is evident that this study is not accepting any more candidates at present although it was posted in October 1st 2022 and last edited a month later. However, 1162 other medical trials are presently recruiting people for participation."

Answered by AI